1. Home
  2. IKNA vs LASE Comparison

IKNA vs LASE Comparison

Compare IKNA & LASE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKNA
  • LASE
  • Stock Information
  • Founded
  • IKNA 2016
  • LASE 2019
  • Country
  • IKNA United States
  • LASE United States
  • Employees
  • IKNA N/A
  • LASE N/A
  • Industry
  • IKNA Biotechnology: Pharmaceutical Preparations
  • LASE Industrial Machinery/Components
  • Sector
  • IKNA Health Care
  • LASE Industrials
  • Exchange
  • IKNA Nasdaq
  • LASE Nasdaq
  • Market Cap
  • IKNA 63.7M
  • LASE 51.8M
  • IPO Year
  • IKNA 2021
  • LASE 2022
  • Fundamental
  • Price
  • IKNA $1.43
  • LASE $3.04
  • Analyst Decision
  • IKNA Buy
  • LASE
  • Analyst Count
  • IKNA 2
  • LASE 0
  • Target Price
  • IKNA $13.50
  • LASE N/A
  • AVG Volume (30 Days)
  • IKNA 434.6K
  • LASE 495.0K
  • Earning Date
  • IKNA 07-24-2025
  • LASE 07-07-2025
  • Dividend Yield
  • IKNA N/A
  • LASE N/A
  • EPS Growth
  • IKNA N/A
  • LASE N/A
  • EPS
  • IKNA N/A
  • LASE N/A
  • Revenue
  • IKNA N/A
  • LASE $4,962,487.00
  • Revenue This Year
  • IKNA N/A
  • LASE N/A
  • Revenue Next Year
  • IKNA N/A
  • LASE N/A
  • P/E Ratio
  • IKNA N/A
  • LASE N/A
  • Revenue Growth
  • IKNA N/A
  • LASE 23.87
  • 52 Week Low
  • IKNA $0.97
  • LASE $1.58
  • 52 Week High
  • IKNA $1.94
  • LASE $19.80
  • Technical
  • Relative Strength Index (RSI)
  • IKNA 59.83
  • LASE 53.56
  • Support Level
  • IKNA $1.20
  • LASE $2.90
  • Resistance Level
  • IKNA $1.42
  • LASE $3.15
  • Average True Range (ATR)
  • IKNA 0.08
  • LASE 0.41
  • MACD
  • IKNA 0.00
  • LASE -0.02
  • Stochastic Oscillator
  • IKNA 82.26
  • LASE 24.85

About IKNA Ikena Oncology Inc.

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.

About LASE Laser Photonics Corporation

Laser Photonics Corp is an integrated manufacturing company for photonics-based industrial products and solutions, laser cleaning technologies. Its laser-blasting technologies are focused on disrupting the sandblasting and abrasives blasting markets. The company offers a portfolio of integrated laser-blasting solutions for corrosion control, rust removal, de-coating, pre-welding and post-welding, laser cleaning, and surface conditioning. Its laser-blasting solutions are applicable in every industry dealing with materials processing, including automotive, aerospace, healthcare, consumer products, shipbuilding, aerospace, machine manufacturing, nuclear maintenance and de-commissioning, and surface coating.

Share on Social Networks: